Cardiology

Top Story

Ezetimibe plus statin linked to greater plaque regression in patients with PCI

July 28, 2015

Patients who underwent PCI had greater coronary plaque regression when assigned a statin plus ezetimibe compared with those assigned statin monotherapy, according to the results of the PRECISE-IVUS study.

Researchers compared the effects of ezetimibe (Zetia, Merck) plus atorvastatin on lipid profile and coronary atheroma regression with those of atorvastatin alone in Japanese patients who underwent PCI.

Thomas M. Maddox, MD, MSc, FACC, FAHA In the Journals

Diabetes, poor glycemic control linked to death, CV events after CABG

July 28, 2015
In patients with type 1 diabetes, poor glycemic control was associated with increased long-term risk for death and major adverse CV events after CABG in a…
Takashi Nojiri In the Journals

Low-dose olprinone reduces risk for atrial fibrillation after lung cancer surgery

July 28, 2015
The administration of olprinone continuously during lung cancer surgery reduced the risk for atrial fibrillation in patients with elevated preoperative B-type…
In the Journals

REVERE: Left radial access linked to increased operator radiation exposure

July 28, 2015
Patient exposure to radiation appears similar during cardiac catheterization with femoral access, left radial access and right radial access, but operator exposure to…
In the Journals

Statins may lower nonvascular dementia risk in patients with AF

July 27, 2015
Patients with atrial fibrillation who used statins may be less likely to develop nonvascular dementia compared with those who do not use statins.AF is associated with…
More News Headlines »
CME
Cardiology Case Consults

The Patient with Acute Coronary Syndrome

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with acute coronary syndrome.
More »
Video
VIDEO: Joseph Rossano, MD, MS, discusses benefits of VADs for children with advanced HF

VIDEO: Joseph Rossano, MD, MS, discusses benefits of VADs for children with advanced HF

July 17, 2015
PHILADELPHIA — In this video, Joseph Rossano, MD, MS, FAAP, FAAC, medical director of HF/transplantation at…
More »
CME
Antiplatelet Agents in ACS Distinguishing Characteristics Safety and Efficacy

Antiplatelet Agents in ACS: Distinguishing Characteristics, Safety, and Efficacy

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
morganatic-roan morganatic-roan